Revista Espanola de Medicina Nuclear e Imagen Molecular

Scope & Guideline

Enhancing Knowledge in Nuclear Medicine and Imaging

Introduction

Immerse yourself in the scholarly insights of Revista Espanola de Medicina Nuclear e Imagen Molecular with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageMulti-Language
ISSN2253-654x
PublisherELSEVIER ESPANA SLU
Support Open AccessNo
CountrySpain
TypeJournal
Convergefrom 2012 to 2024
AbbreviationREV ESP MED NUCL IMA / Rev. Esp. Med. Nucl. Imagen Mol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA CP-08029, SPAIN

Aims and Scopes

The "Revista Espanola de Medicina Nuclear e Imagen Molecular" focuses on advancing the field of nuclear medicine and molecular imaging through the dissemination of high-quality research. The journal emphasizes the application of innovative imaging techniques and radiopharmaceuticals in diagnosing and treating various medical conditions, particularly cancers.
  1. Nuclear Medicine Applications:
    The journal addresses the use of nuclear medicine techniques, including PET/CT, SPECT, and radiopharmaceutical therapies, in the diagnosis, treatment, and management of diseases, particularly various forms of cancer.
  2. Molecular Imaging Techniques:
    Research published in the journal often explores advanced molecular imaging methods, emphasizing their role in enhancing diagnosis and treatment planning through detailed visualization of biological processes.
  3. Theranostics:
    A key area of focus is the integration of diagnostics and therapeutics, where the journal showcases studies that highlight the use of targeted radiopharmaceuticals for personalized treatment approaches.
  4. Radiomics and Machine Learning:
    The journal includes innovative research on radiomics and machine learning applications in nuclear medicine, aiming to improve diagnostic accuracy and treatment outcomes through advanced image analysis.
  5. Multidisciplinary Approaches:
    The journal promotes collaborative studies and multidisciplinary approaches in nuclear medicine, highlighting the importance of integrating various medical specialties for enhanced patient care.
The journal has adapted to evolving trends in nuclear medicine and molecular imaging, reflecting the latest advancements and interests in the field. This section highlights the emerging themes that are gaining traction in recent publications.
  1. Artificial Intelligence and Imaging:
    There is a growing emphasis on the application of artificial intelligence and machine learning techniques in nuclear medicine, particularly regarding image interpretation and predictive analytics.
  2. Integration of Immunotherapy and Imaging:
    Research exploring the intersection of immunotherapy and nuclear imaging is on the rise, focusing on how imaging can inform treatment responses and patient selection for immunotherapeutic interventions.
  3. Personalized Medicine and Precision Approaches:
    The trend toward personalized medicine is evident, with increasing publications on how molecular imaging can guide tailored treatment strategies based on individual patient profiles.
  4. Cardiovascular Applications of Nuclear Medicine:
    A notable increase in studies focusing on cardiovascular applications of nuclear medicine, particularly in imaging and treatment of cardiac conditions, is emerging as a significant trend.
  5. Health Technology Assessment and Policy Research:
    Emerging themes also include health technology assessments related to nuclear medicine practices, addressing the economic and policy implications of advanced imaging technologies.

Declining or Waning

While certain themes continue to thrive, others have shown signs of decline in prominence within the journal's publications. This section outlines areas that have become less frequent or are gradually being phased out.
  1. Basic Research in Radiopharmaceutical Development:
    There has been a noticeable decrease in papers focusing solely on the basic science of radiopharmaceutical development, possibly due to a shift toward clinical applications and outcomes.
  2. Traditional Imaging Techniques:
    Traditional imaging methods, such as standard X-rays and conventional CT scans, appear to be receiving less attention in favor of more advanced imaging techniques like PET/CT and SPECT.
  3. Niche and Rare Disease Studies:
    Research centered on very niche or rare diseases is becoming less common, as the focus shifts toward more prevalent conditions that align with broader clinical applications and interests.

Similar Journals

American Journal of Nuclear Medicine and Molecular Imaging

Pioneering Research in Molecular Imaging and Radiopharmaceuticals
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-8407Frequency: 6 issues/year

The American Journal of Nuclear Medicine and Molecular Imaging (ISSN: 2160-8407), published by E-CENTURY PUBLISHING CORP, is a distinguished platform for the dissemination of cutting-edge research in the fields of nuclear medicine and molecular imaging. With a commitment to advancing scientific inquiry and clinical applications, this journal serves as a vital resource for researchers, clinicians, and students dedicated to exploring innovative imaging modalities, radiopharmaceuticals, and their applications in diagnosing and treating various medical conditions. Although currently not available as an open-access journal, this publication plays a crucial role in fostering academic dialogue and collaboration within the medical community. Its diverse range of topics and expert contributions underscore its impact in bridging the gap between research findings and clinical practice, making it an essential read for anyone interested in the rapidly evolving landscape of nuclear medicine and imaging technologies.

Tomography

Transforming the landscape of medical imaging and diagnostics.
Publisher: MDPIISSN: 2379-1381Frequency: 6 issues/year

Tomography is an esteemed peer-reviewed journal published by MDPI, focusing on a broad spectrum of topics related to medical imaging and diagnostics. Launched in 2015, this Open Access journal serves as a vital platform for researchers, professionals, and students in the fields of medicine, radiology, nuclear medicine, and imaging. With an impressive impact factor reflecting its relevance, the journal has achieved a quartile ranking of Q2 in both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023. Renowned for disseminating high-quality research, Tomography welcomes original research articles, reviews, and technical notes, fostering innovation and collaboration within the scientific community. Housed in Basel, Switzerland, the journal aims to bridge the gap between fundamental research and clinical application, appealing to a diverse readership eager to advance the field of medical imaging.

EJNMMI Research

Fostering Global Collaboration for Scientific Discovery.
Publisher: SPRINGERISSN: 2191-219XFrequency: 1 issue/year

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Pioneering Innovations in Molecular Imaging
Publisher: SPRINGERISSN: 1619-7070Frequency: 12 issues/year

The European Journal of Nuclear Medicine and Molecular Imaging is a prestigious, peer-reviewed journal published by Springer, dedicated to advancing the field of nuclear medicine and molecular imaging. With an impressive impact factor and ranked in the Q1 category for both Medicine and Radiology, Nuclear Medicine and Imaging, this journal is a pivotal platform for researchers and practitioners to disseminate significant findings from 1996 to the present, reflecting the evolution of the field. The journal boasts a notable Scopus rank, standing at #8 out of 333 in its category, placing it in the top 3% of published works, which highlights its critical importance in shaping contemporary practices and research innovations. Although it does not offer an open-access model, the journal provides various access options to ensure that important research is accessible to professionals, students, and academics alike. Through rigorous peer review and a commitment to high-quality publication, the European Journal of Nuclear Medicine and Molecular Imaging plays an essential role in the advancement of nuclear medicine, contributing to better diagnostic and therapeutic outcomes globally.

Molecular Imaging and Radionuclide Therapy

Transforming research into practice in molecular imaging.
Publisher: GALENOS PUBL HOUSEISSN: 2146-1414Frequency: 3 issues/year

Molecular Imaging and Radionuclide Therapy is an esteemed academic journal published by GALENOS PUBL HOUSE, dedicated to advancing the fields of radiology, nuclear medicine, and imaging. Since its inception, this Open Access journal has facilitated the dissemination of high-quality research and innovative practices in molecular imaging and radionuclide therapy, making it a vital resource for researchers, professionals, and students alike. With an ISSN of 2146-1414 and an E-ISSN of 2147-1959, the journal has established its presence globally while specifically catering to the Turkish academic and medical community. As of 2023, it is ranked #241/333 in the Radiology, Nuclear Medicine and Imaging category on Scopus, holding a respectable Q3 quartile ranking. The journal serves as a platform for sharing impactful findings from 2017 to 2024, reinforcing its commitment to open access since 2011. With a dedication to enhancing the knowledge base in molecular imaging and therapy, it remains an important conduit for scholarly communication and collaborative research developments in this dynamic field.

European Journal of Radiology Open

Pioneering Open Access in Radiological Research
Publisher: ELSEVIERISSN: Frequency: 1 issue/year

The European Journal of Radiology Open, published by Elsevier, has established itself as a pivotal platform for disseminating high-quality research in the field of radiology, nuclear medicine, and imaging since its inception in 2014. This open access journal, holding a commendable Q2 ranking in the esteemed 2023 Scopus categorization, seeks to foster a collaborative environment where researchers, professionals, and students can share innovative findings and advancements. Operating under the E-ISSN 2352-0477, this journal contributes to the broader scientific discourse with a commitment to accessibility and transparency, ensuring that cutting-edge research is available to a global audience. The journal's dual focus on rigorous peer review and rapid publication processes underscores its importance within the academic community, aiming to empower professionals with the latest insights in the dynamic landscape of medical imaging.

Medecine Nucleaire-Imagerie Fonctionnelle et Metabolique

Elevating Standards in Nuclear Medicine Research.
Publisher: ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIERISSN: 0928-1258Frequency: 6 issues/year

Medicine Nucleaire-Imagerie Fonctionnelle et Metabolique is a prominent journal published by Elsevier France-Editions Scientifiques Medicales Elsevier, dedicated to the specialized fields of nuclear medicine and functional imaging. With an ISSN of 0928-1258 and an E-ISSN of 1878-6820, this esteemed publication has been a crucial platform for the dissemination of research and developments in the discipline since its inception in 1993. Covering a wide array of topics within biophysics, radiological and ultrasound technology, and radiology, the journal currently holds a Q4 category ranking in these fields, reflecting its significance within the academic community. Although there are currently no open access options available for readers, the journal caters to a niche audience of researchers, professionals, and students who seek to enhance their understanding of metabolic imaging and its applications. The 2023 Scopus ranks indicate its position as an emerging source of knowledge in a competitive landscape, making it an important resource for the latest studies and innovations in nuclear medicine.

Indian Journal of Radiology and Imaging

Pioneering Research for Tomorrow's Imaging Solutions
Publisher: THIEME MEDICAL PUBL INCISSN: 0971-3026Frequency: 4 issues/year

The Indian Journal of Radiology and Imaging, published by THIEME MEDICAL PUBL INC, is a prominent open-access journal in the field of radiology, nuclear medicine, and imaging. Since its inception in 1984, the journal has provided a platform for researchers, professionals, and students to disseminate innovative research and findings in diagnostic imaging. With a growing impact factor and categorized in the Q3 quartile according to the 2023 rankings, it ranks among the notable journals in its field, although it currently stands at Rank #244 out of 333 within Scopus, reflecting its competitive position in radiology research. The journal, accessible to a global audience since 1999, aims to advance the knowledge and practice in imaging by inviting diverse contributions, including original research articles, reviews, and case reports. Its commitment to open-access publication fosters wider dissemination and collaborative discourse, crucial for the dynamic landscape of medical imaging.

NUCLEAR MEDICINE REVIEW

Unveiling Breakthroughs in Imaging Techniques
Publisher: VIA MEDICAISSN: 1506-9680Frequency: 2 issues/year

NUCLEAR MEDICINE REVIEW is a distinguished journal in the field of radiology, nuclear medicine, and imaging, published by VIA MEDICA in Poland. Since its transition to an open access format in 1999, this journal has been dedicated to promoting the dissemination of knowledge and research findings across a global audience. With a focus on innovative approaches and advancements in nuclear medicine, it aims to serve as a key resource for researchers, professionals, and students who are working to further the understanding of nuclear imaging and its applications. In 2023, the journal was classified in the Q3 category within Radiology, Nuclear Medicine and Imaging, and Q4 in the broader category of Medicine (miscellaneous), highlighting its growing reputation in the academic community. As of the latest assessments, the journal has been ranked #235 out of 333 in its field according to Scopus metrics, reflecting its commitment to excellence and the relevance of its published works. The NUCLEAR MEDICINE REVIEW is a pivotal platform for those engaged in cutting-edge research, providing insights that drive the evolution of medical imaging and therapeutic techniques.

Molecular Imaging

Transforming Insights into Innovations in Imaging.
Publisher: SAGE PUBLICATIONS INCISSN: Frequency: 1 issue/year

Molecular Imaging is a prominent journal published by SAGE Publications Inc., which serves as a vital platform for the dissemination of high-quality research in the field of molecular imaging. With an E-ISSN of 1536-0121, this journal has established itself within several key areas, including Biomedical Engineering, Biotechnology, Condensed Matter Physics, Molecular Medicine, and Radiology, Nuclear Medicine and Imaging. Spanning from 2002 to 2024 and currently classified within the prestigious Q2 and Q3 quartiles, Molecular Imaging aims to highlight the latest developments and innovative methodologies in molecular imaging techniques and applications. Researchers from diverse backgrounds will find the journal's content valuable for staying updated with recent advancements, evidenced by its competitive Scopus ranking and a commitment to fostering interdisciplinary collaboration. Although the journal is not open access, the rigorous peer-review process ensures that all published articles provide significant contributions to the field, making it an essential resource for professionals, researchers, and students alike.